glp-1 vertigo meds like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular glp 1 cause vertigo Potential

In October 2022, the regulator issued a CRL, requesting additional information and analysis related to the infusion device and drug product across several areas of the New Drug Application (NDA)

The only FDA-approved semaglutide products are Rybelsus, Ozempic, and Wegovy , manufactured by Novo Nordisk Inc

Never leave medication in a car during cold weather any more than you would in summer

L-Carnitine's job is to transport fatty acids into your cells to be burned as energy

Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: an elephant in the room